Colin McCall is a partner in the IP/IT group at Taylor Wessing. His practice focuses on the life sciences and medtech sectors. Colin advises biotech, pharmaceutical and medtech companies ranging from early stage fast growth biotechs to listed multinational pharmaceutical and medical devices companies across the full range of commercial contracts – from general commercial agreements to the more complex manufacturing, R&D collaboration and licensing/partnering agreements. Colin also has particular expertise in advising on the commercial and intellectual property aspects of technology transactions including spin-outs, start-ups, venture capital investments, M&A and IPOs.
Live online, Classroom
A three-day practical and interactive seminar focusing on current contract drafting, negotiating, best practice and related issues within the pharmaceutical, biotech and life sciences sectors.